Nano-X Imaging Ltd. (NASDAQ:NNOX - Free Report) - Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Nano-X Imaging in a research report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn anticipates that the company will earn ($0.61) per share for the year. Cantor Fitzgerald currently has a "Overweight" rating and a $12.00 target price on the stock. The consensus estimate for Nano-X Imaging's current full-year earnings is ($0.92) per share.
Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last issued its quarterly earnings data on Thursday, November 21st. The company reported ($0.23) earnings per share for the quarter. Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%. During the same quarter in the prior year, the firm posted ($0.37) earnings per share.
Separately, D. Boral Capital began coverage on Nano-X Imaging in a research note on Monday, January 6th. They issued a "buy" rating and a $23.00 price objective for the company.
Check Out Our Latest Stock Report on Nano-X Imaging
Nano-X Imaging Stock Down 2.8 %
NNOX traded down $0.25 during trading on Thursday, hitting $8.75. The company's stock had a trading volume of 2,609,246 shares, compared to its average volume of 4,869,558. The business's 50 day simple moving average is $7.32 and its 200-day simple moving average is $6.94. The firm has a market cap of $505.58 million, a PE ratio of -10.29 and a beta of 1.97. Nano-X Imaging has a one year low of $5.26 and a one year high of $14.28.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the business. Farther Finance Advisors LLC bought a new position in Nano-X Imaging during the 3rd quarter valued at about $25,000. Verition Fund Management LLC bought a new position in shares of Nano-X Imaging during the third quarter valued at approximately $88,000. Gainplan LLC purchased a new stake in shares of Nano-X Imaging in the fourth quarter worth approximately $92,000. Creative Planning bought a new stake in shares of Nano-X Imaging during the 3rd quarter worth approximately $107,000. Finally, Intech Investment Management LLC purchased a new position in Nano-X Imaging during the 3rd quarter valued at $124,000. Institutional investors own 21.49% of the company's stock.
Nano-X Imaging Company Profile
(
Get Free Report)
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Further Reading
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.